Valued at $90.0M at its early-stage round, Jan 2026. Nothing has traded since.
- ·Watch Converge Bio: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Converge Bio funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Jan 2026 | Early Stage VC (Series A) | $25.0M | ▮ | ▮ |
Membership and data by Private Market View
Converge Bio valuation
Converge Bio was valued at $90 million at its early-stage round in Jan 2026. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Converge Bio raised?
Converge Bio has raised $30.5 million across 1 recorded round since 2026. The largest was a $25 million Series A in Jan 2026.
Converge Bio has filed 1 Form D with the SEC, most recently in Apr 2026 ($25 million sold to 19 investors).
Institutional holders and vehicles
In the last 12 months, 1 investment vehicle was formed to buy Converge Bio shares, reporting $154,500 sold to 2 investors, per SEC Form D filings (most recent Oct 2025).
How Converge Bio's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Converge Bio, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Converge Bio
- What is Converge Bio worth?
- Converge Bio is valued at $90.0M as of Oct 2026. Valued at $90.0M at its early-stage round, Jan 2026. Nothing has traded since.
- How much has Converge Bio raised?
- Converge Bio has raised $30.5M in total funding across 1 recorded rounds.
- When did Converge Bio last raise?
- Converge Bio last raised in Jan 2026 (Early Stage VC (Series A)), raising $25.0M.